P2X7 Receptor Activation Impairs Exogenous MHC Class I Oligopeptides Presentation in Antigen Presenting Cells

PLoS ONE

Volumn 8, Issue 8, 2013, Pages

  Baroja Mazo, Alberto ^a   Barberà Cremades, Maria ^a   Pelegrín, Pablo ^a  

^a HOSPITAL UNIVERSITARIO VIRGEN DE LA ARRIXACA   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINE TRIPHOSPHATE; LACTATE DEHYDROGENASE; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; OLIGOPEPTIDE; PURINERGIC P2X7 RECEPTOR;

ADAPTIVE IMMUNITY; ANIMAL CELL; ANIMAL TISSUE; ANTIGEN EXPRESSION; ANTIGEN PRESENTATION; ANTIGEN PRESENTING CELL; APOPTOSIS; ARTICLE; CALCIUM SIGNALING; CD8+ T LYMPHOCYTE; CELLULAR IMMUNITY; CONTROLLED STUDY; ENZYME RELEASE; FEMALE; IMMUNOREACTIVITY; MACROPHAGE ACTIVATION; MAJOR HISTOCOMPATIBILITY COMPLEX; MALE; MOUSE; NONHUMAN; PROTEIN DEGRADATION; PROTEIN FUNCTION; T LYMPHOCYTE ACTIVATION;

ANIMALS; ANTIGEN-PRESENTING CELLS; CD8-POSITIVE T-LYMPHOCYTES; CELLS, CULTURED; FEMALE; GENES, MHC CLASS I; INTERLEUKIN-1BETA; MACROPHAGES; MALE; MICE; MICE, INBRED C57BL; OLIGOPEPTIDES; PURINERGIC P2X RECEPTOR ANTAGONISTS; PYRIDINES; RECEPTORS, PURINERGIC P2X7; TETRAZOLES;

EID: 84881094843     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0070577     Document Type: Article

References (54)

1. Adams DO, Hamilton TA, (1984) The cell biology of macrophage activation. Annu Rev Immunol 2: 283-318.
2. Polyak S, Chen H, Hirsch D, George I, Hershberg R, et al. (1997) Impaired class II expression and antigen uptake in monocytic cells after HIV-1 infection. J Immunol 159: 2177-2188.
3. Mellman I, Steinman RM, (2001) Dendritic cells: specialized and regulated antigen processing machines. Cell 106: 255-258.
4. Trombetta ES, Ebersold M, Garrett W, Pypaert M, Mellman I, (2003) Activation of lysosomal function during dendritic cell maturation. Science 299: 1400-1403.
5. Henderson RA, Michel H, Sakaguchi K, Shabanowitz J, Appella E, et al. (1992) HLA-A2.1-associated peptides from a mutant cell line: a second pathway of antigen presentation. Science 255: 1264-1266.
6. Kurts C, Heath WR, Carbone FR, Allison J, Miller JF, et al. (1996) Constitutive class I-restricted exogenous presentation of self antigens in vivo. J Exp Med 184: 923-930.
7. Neefjes J, Jongsma ML, Paul P, Bakke O, (2011) Towards a systems understanding of MHC class I and MHC class II antigen presentation. Nat Rev Immunol 11: 823-836.
8. Win SJ, Ward VK, Dunbar PR, Young SL, Baird MA, (2011) Cross-presentation of epitopes on virus-like particles via the MHC I receptor recycling pathway. Immunol Cell Biol 89: 681-688.
9. Hughes EA, Hammond C, Cresswell P, (1997) Misfolded major histocompatibility complex class I heavy chains are translocated into the cytoplasm and degraded by the proteasome. Proc Natl Acad Sci U S A 94: 1896-1901.
10. Barbera-Cremades M, Baroja-Mazo A, Gomez AI, Machado F, Di Virgilio F, et al. (2012) P2X7 receptor-stimulation causes fever via PGE2 and IL-1beta release. FASEB J 26: 2951-2962.
11. Idzko M, Hammad H, van Nimwegen M, Kool M, Willart MA, et al. (2007) Extracellular ATP triggers and maintains asthmatic airway inflammation by activating dendritic cells. Nat Med 13: 913-919.
12. Weber FC, Esser PR, Muller T, Ganesan J, Pellegatti P, et al. (2010) Lack of the purinergic receptor P2X(7) results in resistance to contact hypersensitivity. J Exp Med 207: 2609-2619.
13. Wilhelm K, Ganesan J, Muller T, Durr C, Grimm M, et al. (2010) Graft-versus-host disease is enhanced by extracellular ATP activating P2X7R. Nat Med 16: 1434-1438.
14. Ferrari D, Pizzirani C, Adinolfi E, Lemoli RM, Curti A, et al. (2006) The P2X7 receptor: a key player in IL-1 processing and release. J Immunol 176: 3877-3883.
15. Lopez-Castejon G, Theaker J, Pelegrin P, Clifton AD, Braddock M, et al. (2010) P2X(7) receptor-mediated release of cathepsins from macrophages is a cytokine-independent mechanism potentially involved in joint diseases. J Immunol 185: 2611-2619.
16. Moore SF, MacKenzie AB, (2009) NADPH oxidase NOX2 mediates rapid cellular oxidation following ATP stimulation of endotoxin-primed macrophages. J Immunol 183: 3302-3308.
17. Qu Y, Ramachandra L, Mohr S, Franchi L, Harding CV, et al. (2009) P2X7 receptor-stimulated secretion of MHC class II-containing exosomes requires the ASC/NLRP3 inflammasome but is independent of caspase-1. J Immunol 182: 5052-5062.
18. Chessell IP, Hatcher JP, Bountra C, Michel AD, Hughes JP, et al. (2005) Disruption of the P2X7 purinoceptor gene abolishes chronic inflammatory and neuropathic pain. Pain 114: 386-396.
19. Keating C, Pelegrin P, Martinez CM, Grundy D, (2011) P2X7 receptor-dependent intestinal afferent hypersensitivity in a mouse model of postinfectious irritable bowel syndrome. J Immunol 187: 1467-1474.
20. King BF, (2007) Novel P2X7 receptor antagonists ease the pain. Br J Pharmacol 151: 565-567.
21. Riteau N, Gasse P, Fauconnier L, Gombault A, Couegnat M, et al. (2010) Extracellular ATP is a danger signal activating P2X7 receptor in lung inflammation and fibrosis. Am J Respir Crit Care Med 182: 774-783.
22. Arulkumaran N, Unwin RJ, Tam FW, (2011) A potential therapeutic role for P2X7 receptor (P2X7R) antagonists in the treatment of inflammatory diseases. Expert Opin Investig Drugs 20: 897-915.
23. Solle M, Labasi J, Perregaux DG, Stam E, Petrushova N, et al. (2001) Altered cytokine production in mice lacking P2X(7) receptors. J Biol Chem 276: 125-132.
24. Lopez-Castejon G, Baroja-Mazo A, Pelegrin P, (2011) Novel macrophage polarization model: from gene expression to identification of new anti-inflammatory molecules. Cell Mol Life Sci 68: 3095-3107.
25. North RA, (2002) Molecular physiology of P2X receptors. Physiol Rev 82: 1013-1067.
26. Pellegatti P, Falzoni S, Pinton P, Rizzuto R, Di Virgilio F, (2005) A novel recombinant plasma membrane-targeted luciferase reveals a new pathway for ATP secretion. Mol Biol Cell 16: 3659-3665.
27. Fransen MF, van Stipdonk MJ, Sluijter M, Schoenberger SP, Melief CJ, et al. (2010) Separate roles for antigen recognition and lymph node inflammation in CD8+ memory T cell formation. J Immunol 185: 3167-3173.
28. Maroof A, Beattie L, Kirby A, Coles M, Kaye PM, (2009) Dendritic cells matured by inflammation induce CD86-dependent priming of naive CD8+ T cells in the absence of their cognate peptide antigen. J Immunol 183: 7095-7103.
29. Aleyas AG, Han YW, Patil AM, Kim SB, Kim K, et al. (2012) Impaired cross-presentation of CD8alpha(+) CD11c(+) dendritic cells by Japanese encephalitis virus in a TLR2/MyD88 signal pathway-dependent manner. Eur J Immunol doi:10.1002/eji.201142052.
30. Simmons DP, Canaday DH, Liu Y, Li Q, Huang A, et al. (2010) Mycobacterium tuberculosis and TLR2 agonists inhibit induction of type I IFN and class I MHC antigen cross processing by TLR9. J Immunol 185: 2405-2415.
31. Smed-Sorensen A, Chalouni C, Chatterjee B, Cohn L, Blattmann P, et al. (2012) Influenza A virus infection of human primary dendritic cells impairs their ability to cross-present antigen to CD8 T cells. PLoS Pathog 8: e1002572.
32. Santos SG, Powis SJ, Arosa FA, (2004) Misfolding of major histocompatibility complex class I molecules in activated T cells allows cis-interactions with receptors and signaling molecules and is associated with tyrosine phosphorylation. J Biol Chem 279: 53062-53070.
33. Demaria S, Schwab R, Gottesman SR, Bushkin Y, (1994) Soluble beta 2-microglobulin-free class I heavy chains are released from the surface of activated and leukemia cells by a metalloprotease. J Biol Chem 269: 6689-6694.
34. Gu BJ, Wiley JS, (2006) Rapid ATP-induced release of matrix metalloproteinase 9 is mediated by the P2X7 receptor. Blood 107: 4946-4953.
35. Hanley PJ, Kronlage M, Kirschning C, del Rey A, Di Virgilio F, et al. (2012) Transient P2X7 receptor activation triggers macrophage death independent of Toll-like receptors 2 and 4, caspase-1, and pannexin-1 proteins. J Biol Chem 287: 10650-10663.
36. Marques-da-Silva C, Chaves MM, Rodrigues JC, Corte-Real S, Coutinho-Silva R, et al. (2011) Differential modulation of ATP-induced P2X7-associated permeabilities to cations and anions of macrophages by infection with Leishmania amazonensis. PLoS One 6: e25356.
37. Compeer EB, Flinsenberg TW, van der Grein SG, Boes M, (2012) Antigen processing and remodeling of the endosomal pathway: requirements for antigen cross-presentation. Front Immunol 3: 37.
38. Gromme M, Uytdehaag FG, Janssen H, Calafat J, van Binnendijk RS, et al. (1999) Recycling MHC class I molecules and endosomal peptide loading. Proc Natl Acad Sci U S A 96: 10326-10331.
39. Hsu C, Morohashi Y, Yoshimura S, Manrique-Hoyos N, Jung S, et al. (2010) Regulation of exosome secretion by Rab35 and its GTPase-activating proteins TBC1D10A-C. J Cell Biol 189: 223-232.
40. Savina A, Furlan M, Vidal M, Colombo MI, (2003) Exosome release is regulated by a calcium-dependent mechanism in K562 cells. J Biol Chem 278: 20083-20090.
41. MacKenzie A, Wilson HL, Kiss-Toth E, Dower SK, North RA, et al. (2001) Rapid secretion of interleukin-1beta by microvesicle shedding. Immunity 15: 825-835.
42. Petersen TR, Dickgreber N, Hermans IF, (2010) Tumor antigen presentation by dendritic cells. Crit Rev Immunol 30: 345-386.
43. Kaczmarek M, Frydrychowicz M, Rubis B, Mizera-Nyczak E, Nieruchalska E, et al. (2007) Analysis of expression of MHC class I molecules and TAP genes in malignant human cell lines. Folia Histochem Cytobiol 45: 205-214.
44. Li Y, Wang LX, Yang G, Hao F, Urba WJ, et al. (2008) Efficient cross-presentation depends on autophagy in tumor cells. Cancer Res 68: 6889-6895.
45. Pang B, Neefjes J, (2010) Coupled for cross-presentation in tumor immunotherapy. Sci Transl Med 2: 44ps40.
46. Gerlini G, Tun-Kyi A, Dudli C, Burg G, Pimpinelli N, et al. (2004) Metastatic melanoma secreted IL-10 down-regulates CD1 molecules on dendritic cells in metastatic tumor lesions. Am J Pathol 165: 1853-1863.
47. Rabinovich GA, Gabrilovich D, Sotomayor EM, (2007) Immunosuppressive strategies that are mediated by tumor cells. Annu Rev Immunol 25: 267-296.
48. Biswas SK, Mantovani A, (2010) Macrophage plasticity and interaction with lymphocyte subsets: cancer as a paradigm. Nat Immunol 11: 889-896.
49. Mantovani A, Sica A, (2010) Macrophages, innate immunity and cancer: balance, tolerance, and diversity. Curr Opin Immunol 22: 231-237.
50. Pellegatti P, Raffaghello L, Bianchi G, Piccardi F, Pistoia V, et al. (2008) Increased level of extracellular ATP at tumor sites: in vivo imaging with plasma membrane luciferase. PLoS One 3: e2599.
51. Pelegrin P, Surprenant A, (2009) Dynamics of macrophage polarization reveal new mechanism to inhibit IL-1beta release through pyrophosphates. EMBO J 28: 2114-2127.
52. Adinolfi E, Raffaghello L, Giuliani AL, Cavazzini L, Capece M, et al. (2012) Expression of P2X7 receptor increases in vivo tumor growth. Cancer Res 72: 2957-2969.
53. Jelassi B, Chantome A, Alcaraz-Perez F, Baroja-Mazo A, Cayuela ML, et al. (2011) P2X(7) receptor activation enhances SK3 channels- and cystein cathepsin-dependent cancer cells invasiveness. Oncogene 30: 2108-2122.
54. Roger S, Pelegrin P, (2011) P2X7 receptor antagonism in the treatment of cancers. Expert Opin Investig Drugs 20: 875-880.